OBJECTIVE: Descriptions of the inpatient experience for patients hospitalized with systolic heart failure (HF) are limited and lack a cross-sectional representation of the US population. While length of stay (LOS) is a primary determinant of resource use and post-discharge events, few models exist for estimating LOS. RESEARCH DESIGN AND METHODS: MarketScan(®) administrative claims data from 1/1/2005-6/30/2008 were used to select hospitalized patients aged ≥18 years with discharge diagnoses for both HF (primary diagnosis) and systolic HF (any diagnostic position) without prior HF hospitalization or undergoing transplantation. RESULTS: Among 17,597 patients with systolic HF; 4109 had commercial; 2118 had Medicaid; and 11,370 had Medicare payer type. Medicaid patients had longer mean LOS (7.1 days) than commercial (6.3 days) or Medicare (6.7 days). In-hospital mortality was highest for patients with Medicaid (2.4%), followed by Medicare (1.3%) and commercial (0.6%). Commercial patients were more likely to receive inpatient procedures. Renal failure, pressure ulcer, malnutrition, a non-circulatory index admission DRG, receipt of a coronary artery bypass procedure or cardiac catheterization, or need for mechanical ventilation during the index admission were associated with increased LOS; receipt of a pacemaker device at index was associated with shorter LOS. LIMITATIONS: Selection of patients with systolic HF is limited by completeness and accuracy of medical coding, and results may not be generalizable to patients with diastolic HF or to international populations. CONCLUSION: Inpatient care, LOS, and in-hospital survival differ by payer among patients hospitalized with systolic HF, although co-morbidity and inpatient procedures consistently influence LOS across payer types. These findings may refine risk stratification, allowing for targeted intensive inpatient management and/or aggressive transitional care to improve outcomes and increase the efficiency of care.
OBJECTIVE: Descriptions of the inpatient experience for patients hospitalized with systolic heart failure (HF) are limited and lack a cross-sectional representation of the US population. While length of stay (LOS) is a primary determinant of resource use and post-discharge events, few models exist for estimating LOS. RESEARCH DESIGN AND METHODS: MarketScan(®) administrative claims data from 1/1/2005-6/30/2008 were used to select hospitalized patients aged ≥18 years with discharge diagnoses for both HF (primary diagnosis) and systolic HF (any diagnostic position) without prior HF hospitalization or undergoing transplantation. RESULTS: Among 17,597 patients with systolic HF; 4109 had commercial; 2118 had Medicaid; and 11,370 had Medicare payer type. Medicaid patients had longer mean LOS (7.1 days) than commercial (6.3 days) or Medicare (6.7 days). In-hospital mortality was highest for patients with Medicaid (2.4%), followed by Medicare (1.3%) and commercial (0.6%). Commercial patients were more likely to receive inpatient procedures. Renal failure, pressure ulcer, malnutrition, a non-circulatory index admission DRG, receipt of a coronary artery bypass procedure or cardiac catheterization, or need for mechanical ventilation during the index admission were associated with increased LOS; receipt of a pacemaker device at index was associated with shorter LOS. LIMITATIONS: Selection of patients with systolic HF is limited by completeness and accuracy of medical coding, and results may not be generalizable to patients with diastolic HF or to international populations. CONCLUSION: Inpatient care, LOS, and in-hospital survival differ by payer among patients hospitalized with systolic HF, although co-morbidity and inpatient procedures consistently influence LOS across payer types. These findings may refine risk stratification, allowing for targeted intensive inpatient management and/or aggressive transitional care to improve outcomes and increase the efficiency of care.
Authors: John R Kapoor; Roger Kapoor; Anne S Hellkamp; Adrian F Hernandez; Paul A Heidenreich; Gregg C Fonarow Journal: J Am Coll Cardiol Date: 2011-09-27 Impact factor: 24.094
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: Ruben Amarasingham; Billy J Moore; Ying P Tabak; Mark H Drazner; Christopher A Clark; Song Zhang; W Gary Reed; Timothy S Swanson; Ying Ma; Ethan A Halm Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Qian Li; Robert J Glynn; Nancy A Dreyer; Jun Liu; Helen Mogun; Soko Setoguchi Journal: Pharmacoepidemiol Drug Saf Date: 2011-05-14 Impact factor: 2.890
Authors: JoAnn Lindenfeld; Nancy M Albert; John P Boehmer; Sean P Collins; Justin A Ezekowitz; Michael M Givertz; Stuart D Katz; Marc Klapholz; Debra K Moser; Joseph G Rogers; Randall C Starling; William G Stevenson; W H Wilson Tang; John R Teerlink; Mary N Walsh Journal: J Card Fail Date: 2010-06 Impact factor: 5.712
Authors: David J Whellan; Xin Zhao; Adrian F Hernandez; Li Liang; Eric D Peterson; Deepak L Bhatt; Paul A Heidenreich; Lee H Schwamm; Gregg C Fonarow Journal: J Card Fail Date: 2011-05-31 Impact factor: 5.712
Authors: Carl van Walraven; Irfan A Dhalla; Chaim Bell; Edward Etchells; Ian G Stiell; Kelly Zarnke; Peter C Austin; Alan J Forster Journal: CMAJ Date: 2010-03-01 Impact factor: 8.262
Authors: Héctor Bueno; Joseph S Ross; Yun Wang; Jersey Chen; María T Vidán; Sharon-Lise T Normand; Jeptha P Curtis; Elizabeth E Drye; Judith H Lichtman; Patricia S Keenan; Mikhail Kosiborod; Harlan M Krumholz Journal: JAMA Date: 2010-06-02 Impact factor: 56.272
Authors: Karen K Ballen; Steven Joffe; Ruta Brazauskas; Zhiwei Wang; Mahmoud D Aljurf; Görgün Akpek; Christopher Dandoy; Haydar A Frangoul; César O Freytes; Nandita Khera; Hillard M Lazarus; Charles F LeMaistre; Paulette Mehta; Susan K Parsons; David Szwajcer; Celalettin Ustun; William A Wood; Navneet S Majhail Journal: Biol Blood Marrow Transplant Date: 2014-07-23 Impact factor: 5.742
Authors: Mica Curtin-Bowen; Troy Li; Avery Pullman; Alexandra Businger; Stuart Lipsitz; Ania Syrowatka; Michael Sainlaire; Tien Thai; Jay Lieberman; Aileen Davis; Bonnie Blanchfield; David W Bates; Patricia C Dykes Journal: AMIA Annu Symp Proc Date: 2022-02-21
Authors: Matthew Shane Loop; Melissa K Van Dyke; Ligong Chen; Todd M Brown; Raegan W Durant; Monika M Safford; Emily B Levitan Journal: Am J Cardiol Date: 2016-04-21 Impact factor: 2.778
Authors: Xue Song; Ruben G W Quek; Shravanthi R Gandra; Katherine A Cappell; Robert Fowler; Ze Cong Journal: BMC Health Serv Res Date: 2015-06-25 Impact factor: 2.655